Showing results (11-20 of 160) with videos related to
Sort By:
Pageof 16
Pharmacogenomics|June 2, 2016
Pharmacogenetics of ribavirin-induced anemia in HCV patientsAntonio D'Avolio, Jessica Cusato, Amedeo De Nicolò, et al.Pharmacogenomics|April 5, 2016
Role of pharmacogenetics on deferasirox AUC and efficacyJessica Cusato, Sarah Allegra, Silvia De Francia, et al.Archives of Virology|June 11, 2015
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatmentLucio Boglione, Jessica Cusato, Sarah Allegra, et al.Archives of Virology|February 13, 2021
Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective studyLucio Boglione, Ilaria De Benedetto, Tommaso Lupia, et al.The Journal of Pharmacy and Pharmacology|May 28, 2016
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patientsSarah Allegra, Jessica Cusato, Silvia De Francia, et al.Molecules (Basel, Switzerland)|February 15, 2022
Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from "Integriamoci", a Pilot Pharmacokinetic StudyValeria Avataneo, Alice Palermiti, Amedeo De Nicolò, et al.The Journal of Pharmacy and Pharmacology|September 28, 2016
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatmentSarah Allegra, Silvia De Francia, Jessica Cusato, et al.Geriatric Nursing (New York, N.Y.)|January 24, 2026
Association between anticholinergic burden scales and recurrent falls in independently living older adults: a cross-sectional studyElena Casabona, Jessica Cusato, Marco Clari, et al.The Pharmacogenomics Journal|October 18, 2019
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patientsJessica Cusato, Andrea Calcagno, Letizia Marinaro, et al.International Journal of Antimicrobial Agents|July 23, 2016
Entecavir plasma concentrations are inversely related to HBV-DNA decrease in a cohort of treatment-naïve patients with chronic hepatitis BLucio Boglione, Amedeo De Nicolò, Jessica Cusato, et al.Pageof 16